Transcept Pharmaceuticals: Deep Value, Quick Return PossibleRupert Hargreaves
Transcept Pharmaceuticals Inc (NASDAQ:TSPT) is a speciality pharmaceutical company focused on the development of products that address the therapeutic needs in the field of neuroscience. At present the company has a market capitalization of $66.3 million and an average daily volume of 150,580 shares.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.